EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Research Priorities and Future Directions in Cardio-Oncology

Reed Mszar, Abdelrahman Ali, Sarah C Hull, Leah M Ferrucci, Lauren A Baldassarre, Rohan Khera, Melinda L Irwin, Suparna C Clasen

Current Treatment Options in Oncology · 2026-12 · 27 (1)

DOI: 10.1007/s11864-025-01366-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, online erschienen am 04.01.2026. Verfasst von Reed Mszar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, 06510, USA. reed.mszar@yale.edu. Hauptthemen laut MEDLINE: Neoplasms, Cardiovascular Diseases, Medical Oncology, Cardiology. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 124 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OPINION STATEMENT: The subspecialty of cardio-oncology has undergone significant growth in recent years, alongside major advances in the management of both cardiovascular disease and cancer, the leading causes of morbidity and mortality in the United States and many countries around the world. Contemporary clinical guidelines and scientific statements have outlined evidence-based strategies for reducing the risk of cancer therapy-related cardiovascular toxicity among cancer survivors across the treatment continuum. These approaches broadly include tailoring assessment and treatment of shared risk factors before therapy; minimizing cardiac radiation exposure, integrating baseline and repeat echocardiography for those receiving anthracyclines and targeted therapies, and assessing troponins and electrocardiography for patients starting immune checkpoint inhibitors during therapy; and considering long-term cardiac surveillance and promoting healthy lifestyle behaviors after therapy. This review outlines key evidence gaps and future directions in cardio-oncology with an emphasis on contemporary trends in cardiovascular disease and cancer risk factors, current and novel approaches for risk estimation and stratification, innovative clinical trials and largescale observational registries, quality-of-care metrics and cardio-oncology rehabilitation, social determinants of health and health equity, and artificial intelligence and machine learning for precision medicine. As the number of cancer survivors continues to grow and is projected to exceed 26 million by 2040, multidisciplinary collaboration between cardiology, oncology, and other health disciplines is critical to not only improve individuals' health outcomes and quality of life associated with cardiovascular disease and cancer, but also to further elucidate the bi-directional relationship and underlying pathophysiologic mechanisms underpinning both chronic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCardiovascular DiseasesMedical OncologyCardiologyHumansRisk FactorsDisease ManagementCardiotoxicityCardio-Oncology

Stichwörter der Autor:innen

CancerCardio-oncologyCardiotoxicityCardiovascular diseaseRisk factorsSurvivorship

Autor:innen und Institutionen

  • Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, 06510, USA. reed.mszar@yale.edu.
  • Division of Cardiology, University of Texas Medical Branch, Galveston, TX, USA.
  • Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA.
  • Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Yale Cancer Center, New Haven, CT, USA.
  • Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.

Zitieren

APA

Mszar, R., Ali, A., Hull, S. C., Ferrucci, L. M., Baldassarre, L. A., Khera, R., Irwin, M. L., & Clasen, S. C. (2026). Research Priorities and Future Directions in Cardio-Oncology. Current Treatment Options in Oncology, 27(1). https://doi.org/10.1007/s11864-025-01366-w

Vancouver

Mszar R, Ali A, Hull SC, Ferrucci LM, Baldassarre LA, Khera R, et al. Research Priorities and Future Directions in Cardio-Oncology. Current Treatment Options in Oncology. 2026;27(1). doi:10.1007/s11864-025-01366-w

BibTeX
@article{Mszar2026,
  author = {Mszar, Reed and Ali, Abdelrahman and Hull, Sarah C and Ferrucci, Leah M and Baldassarre, Lauren A and Khera, Rohan and Irwin, Melinda L and Clasen, Suparna C},
  title = {Research Priorities and Future Directions in Cardio-Oncology},
  journal = {Current Treatment Options in Oncology},
  year = {2026},
  volume = {27},
  number = {1},
  doi = {10.1007/s11864-025-01366-w}
}
Kostenlos starten →